Background illustration for clinical trials search

Paid Clinical Trials Kentucky

Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

for
Acute Respiratory Failure
Location: Louisville KY
Sponsor: University of Louisville

Sex: All

Age: 18 - 70+

Code: NCT05144633

Recruiting

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

for
Peritoneal Carcinomatosis
Location: Burlington VT, Lexington KY
Sponsor: Prakash Pandalai

Sex: All

Age: 18+

Code: NCT04779554

Phase 2, Recruiting

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

for
Post Operative Surgical Site Infection
Location: Boston MA, Providence RI, Lebanon NH, Jamaica NY,
Sponsor: Major Extremity Trauma Research Consortium

Sex: All

Age: 18 - 64

Code: NCT04678154

Phase 3, Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

for
Carcinoma, Non-Small Cell Lung
Location: Paramus NJ, Norfolk VA, Fairfax VA, Canton OH,
Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT04486833

Phase 1, Phase 2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: New Brunswick NJ, Toronto, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

for
Infant, Extremely Premature, Obstetric Labor, Premature,
Location: Boston MA, The Bronx NY, Hackensack NJ, Burlington VT,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0 - 1

Code: NCT05685745

Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Halifax, Shirley NY, New York NY, Albany NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

for
Degenerative Disc Disease, Disc Degeneration,
Location: Shrewsbury NJ, New York NY, New Bern NC, Gainesville FL,
Sponsor: VIVEX Biologics, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06778447

Recruiting

Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

for
Cancer
Location: Lexington KY
Sponsor: Rachel Miller

Sex: All

Age: 18+

Code: NCT03089554

Phase 2, Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: Providence RI, Hamden CT, New York NY, Montreal,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

for
Non-small Cell Lung Cancers
Location: Louisville KY
Sponsor: University of Louisville

Sex: All

Age: 18+

Code: NCT01871454

Phase 2, Recruiting

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).

for
Ovarian Cancer Recurrent
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06843447

Phase 1, Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

for
Lung Transplant
Location: Philadelphia PA, Baltimore MD, Columbus OH,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05547698

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Gloucester MA, Beverly MA, Peabody MA, Burlington MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Westbury NY, Fresh Meadows NY, Philadelphia PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase 3, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

for
Non-small Cell Lung Cancer
Location: Philadelphia PA, Baltimore MD, Lexington KY, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06731907

Phase 2, Recruiting

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

for
Gastroparesis, Gastroparesis Nondiabetic,
Location: Tampa FL, Detroit MI, Louisville KY, Saint Louis MO,
Sponsor: Enterra Medical, Inc.

Sex: All

Age: 18 - 70

Code: NCT06560307

Recruiting

Popular cities in Kentucky

LexingtonLouisvilleBowling Green